Presentation TCT 2015

RIVER-PCI: A Prospective, Double-blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Presenter: Giora Weisz

October 13, 2015

REGISTER for free or LOG IN to view this content

RIVER-PCI: A Prospective, Double-blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Presentation

TCT 2015

Up Next

Presentation TCT 2015

Big Data: Opportunities and Challenges 3 Industry Perspectives

Presenter: Keith D. Dawkins

October 13, 2015

More slides +

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Michael Boehm

September 14, 2014

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.